- Home
- GALT vs DSAC Comparison
GALT vs DSAC Comparison
Compare GALT & DSAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$4.01
Company Overview
Basic Information| Metric | GALT | DSAC |
|---|---|---|
| Founded | 2000 | 2025 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 297.0M | 345.6M |
| IPO Year | 2008 | 2025 |
Fundamental Metrics
Financial Performance| Metric | GALT | DSAC |
|---|---|---|
| Price | $4.01 | $10.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 301.3K | 254.6K |
| Earning Date | 05-15-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.03 | $9.90 |
| 52 Week High | $7.13 | $10.47 |
Technical Indicators
Market Signals| Indicator | GALT | DSAC |
|---|---|---|
| Relative Strength Index (RSI) | 52.97 | 50.26 |
| Support Level | $2.74 | $9.90 |
| Resistance Level | $4.35 | $10.18 |
| Average True Range (ATR) | 0.29 | 0.01 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 35.08 | 16.67 |
Price Performance
Historical Comparison GALT
DSAC
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About DSAC Daedalus Special Acquisition Corp. Class A Ordinary Shares
Daedalus Special Acquisition Corp is a blank check company.